|
gptkbp:instanceOf
|
gptkb:drug
|
|
gptkbp:approvalYear
|
1979
|
|
gptkbp:approvedBy
|
gptkb:FDA
|
|
gptkbp:ATCCode
|
J01DC04
|
|
gptkbp:bioavailability
|
95%
|
|
gptkbp:CASNumber
|
53994-73-3
|
|
gptkbp:contraindication
|
hypersensitivity to cephalosporins
|
|
gptkbp:eliminationHalfLife
|
0.6-0.9 hours
|
|
gptkbp:excretion
|
urine
|
|
gptkbp:hasMolecularFormula
|
C15H14ClN3O4S
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
DB320
|
|
gptkbp:indication
|
bacterial infections
|
|
gptkbp:isA
|
second-generation cephalosporin
|
|
gptkbp:mechanismOfAction
|
inhibits bacterial cell wall synthesis
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:molecularWeight
|
367.81 g/mol
|
|
gptkbp:name
|
gptkb:Cefaclor
|
|
gptkbp:pregnancyCategory
|
B (US)
|
|
gptkbp:proteinBinding
|
25%
|
|
gptkbp:PubChem_CID
|
gptkb:DB320
|
|
gptkbp:routeOfAdministration
|
oral
|
|
gptkbp:sideEffect
|
allergic reactions
gastrointestinal disturbances
serum sickness-like reaction
|
|
gptkbp:synonym
|
gptkb:Ceclor
Cefaclorum
|
|
gptkbp:target
|
penicillin-binding proteins
|
|
gptkbp:bfsParent
|
gptkb:Isetemkheb_D
gptkb:Deir_el-Bahari_cache
gptkb:Royal_Cache_(TT320)
gptkb:Unknown_Woman_E
|
|
gptkbp:bfsLayer
|
7
|